| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |